Sublingual (SLIT) Versus Oral Immunotherapy (OIT) for Food Allergy

Emily C. McGowan; Robert A. Wood

doi:10.1007/s11882-014-0486-9

Sublingual (SLIT) Versus Oral Immunotherapy (OIT) for Food Allergy

Emily C. McGowan, Robert A. Wood

School of Medicine

Research output: Contribution to journal › Review article › peer-review

11 Scopus citations

Abstract

Food allergy is a common condition for which the only currently approved treatments are avoidance of the allergenic food and the administration of emergency medications upon accidental exposure. Over the past 10 years, significant advances have been made in the field of food immunotherapy, with efforts focusing on allergen exposure via the oral mucosa. Oral immunotherapy (OIT) and sublingual immunotherapy (SLIT) are the two modalities that have been most extensively studied, and this article will review recent advances in our knowledge of the efficacy and safety of these treatments.

Original language	English (US)
Article number	486
Pages (from-to)	1-9
Number of pages	9
Journal	Current allergy and asthma reports
Volume	14
Issue number	12
DOIs	https://doi.org/10.1007/s11882-014-0486-9
State	Published - Oct 1 2014

Keywords

Food allergy
Immunotherapy
OIT
Omalizumab
SLIT

ASJC Scopus subject areas

Immunology and Allergy
Immunology
Pulmonary and Respiratory Medicine

Access to Document

10.1007/s11882-014-0486-9

Cite this

@article{61beb1a617ae4ee1b4ed0880a334870a,

title = "Sublingual (SLIT) Versus Oral Immunotherapy (OIT) for Food Allergy",

abstract = "Food allergy is a common condition for which the only currently approved treatments are avoidance of the allergenic food and the administration of emergency medications upon accidental exposure. Over the past 10 years, significant advances have been made in the field of food immunotherapy, with efforts focusing on allergen exposure via the oral mucosa. Oral immunotherapy (OIT) and sublingual immunotherapy (SLIT) are the two modalities that have been most extensively studied, and this article will review recent advances in our knowledge of the efficacy and safety of these treatments.",

keywords = "Food allergy, Immunotherapy, OIT, Omalizumab, SLIT",

author = "McGowan, {Emily C.} and Wood, {Robert A.}",

note = "Funding Information: Robert A. Wood reports grants from NIH and royalties from Up to Date. Publisher Copyright: {\textcopyright} 2014, Springer Science+Business Media New York.",

year = "2014",

month = oct,

day = "1",

doi = "10.1007/s11882-014-0486-9",

language = "English (US)",

volume = "14",

pages = "1--9",

journal = "Current allergy and asthma reports",

issn = "1529-7322",

publisher = "Current Medicine Group",

number = "12",

}

TY - JOUR

T1 - Sublingual (SLIT) Versus Oral Immunotherapy (OIT) for Food Allergy

AU - McGowan, Emily C.

AU - Wood, Robert A.

PY - 2014/10/1

Y1 - 2014/10/1

N2 - Food allergy is a common condition for which the only currently approved treatments are avoidance of the allergenic food and the administration of emergency medications upon accidental exposure. Over the past 10 years, significant advances have been made in the field of food immunotherapy, with efforts focusing on allergen exposure via the oral mucosa. Oral immunotherapy (OIT) and sublingual immunotherapy (SLIT) are the two modalities that have been most extensively studied, and this article will review recent advances in our knowledge of the efficacy and safety of these treatments.

AB - Food allergy is a common condition for which the only currently approved treatments are avoidance of the allergenic food and the administration of emergency medications upon accidental exposure. Over the past 10 years, significant advances have been made in the field of food immunotherapy, with efforts focusing on allergen exposure via the oral mucosa. Oral immunotherapy (OIT) and sublingual immunotherapy (SLIT) are the two modalities that have been most extensively studied, and this article will review recent advances in our knowledge of the efficacy and safety of these treatments.

KW - Food allergy

KW - Immunotherapy

KW - OIT

KW - Omalizumab

KW - SLIT

UR - http://www.scopus.com/inward/record.url?scp=84910137710&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84910137710&partnerID=8YFLogxK

U2 - 10.1007/s11882-014-0486-9

DO - 10.1007/s11882-014-0486-9

M3 - Review article

C2 - 25297805

AN - SCOPUS:84910137710

SN - 1529-7322

VL - 14

SP - 1

EP - 9

JO - Current allergy and asthma reports

JF - Current allergy and asthma reports

IS - 12

M1 - 486

ER -

Sublingual (SLIT) Versus Oral Immunotherapy (OIT) for Food Allergy

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this